All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Accommodating lens implanted in first patient ➤ First patient dosed in Phase 2 trial investigating treatment for normal tension glaucoma ➤ Primary endpoint met in Phase 3 trial for glaucoma drop ➤ CE mark approvals ➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy for Stargardt disease ➤ ASCRS news and events
➤ First gene therapy treatment for macular telangiectasia type 2 performed outside of trial ➤ First patient enrolled in Phase 2b study of ocular micro implant for IOP reduction ➤ Fast Track Designation granted to Stargardt gene therapy ➤ FDA Special Protocol Assessment for non-proliferative diabetic retinopathy trial ➤ IDE granted to new glaucoma therapy system ➤ Partnership news ➤ ASCRS news and events
Manual marking, digital marking, manual and digital marking—toric IOL alignment methods continue to be an important topic. Both methods still have a place, and both have their pros and cons. Four physicians discussed their preferences.
➤ Fast Track designation granted to one-time intravitreal gene therapy for geographic atrophy ➤ FDA clears IND for Stargardt gene therapy to move forward into a Phase 1/2 clinical trial ➤ BLA submission for retinitis pigmentosa gene therapy begins ➤ First patient dosed in Phase 1/2 trial evaluating NK therapy ➤ Enrollment complete in Phase 2b trial for PCED therapy ➤ ASCRS news and events
When considering uveitis and cataract surgery, you could be dealing with a patient who you know has uveitis, or you could have a patient who develops a new uveitis after surgery. Three physicians spoke about preop, surgery, and postop considerations.
➤ Results from second Phase 3 pivotal trial for presbyopia drop ➤ Interim Phase 2 data presented on DME, wet AMD treatment ➤ Phase 2 trial to investigate oral DME treatment ➤ First patient dosed in investigational cell therapy for photoreceptor diseases ➤ Phase 1 trial begins for minimally invasive dry AMD treatment ➤ Acquisitions and other company news ➤ ASCRS news and events
➤ Preservative-free fixed-dose combination therapy for glaucoma in development ➤ Rare Pediatric Disease designation granted to investigational Stargardt gene therapy ➤ First patient dosed in genome editing program for corneal dystrophy ➤ ASCRS news and events
➤ Company to begin trial with dual-optic accommodative lens ➤ Phase 2 study to begin for immunoglobulin drops for dry eye ➤ Long-term durability of TED treatment demonstrated ➤ Positive Phase 1/2 data from study evaluating X-linked retinoschisis ➤ Eye drop recall ➤ ASCRS news and events
Regardless of surgical experience level, iris prolapse is something that happens to all surgeons occasionally. As such, knowledge of the risk factors that could predispose a patient to iris prolapse, how to handle the event, and postop considerations are an important refresh from time to time.